Systemic therapy is any medical treatment that travels through your bloodstream to reach cells throughout your entire body. This distinguishes it from local treatments like surgery or radiation, which target one specific area. The term comes up most often in cancer care, where it includes chemotherapy, immunotherapy, targeted therapy, and hormone therapy, but systemic treatments are also used for autoimmune conditions like psoriatic arthritis and psoriasis.
How Systemic Therapy Differs From Local Treatment
Surgery removes a tumor from one location. Radiation bombards a defined area with energy to destroy cancer cells there. Both are local: they treat what they can physically reach. Systemic therapy works differently. Once a drug enters your bloodstream, it circulates everywhere, which makes it capable of attacking cancer cells that may have spread to distant parts of the body or are too small to detect on imaging.
This whole-body reach is both the advantage and the challenge. Systemic drugs can find and damage cancer cells hiding in organs far from the original tumor, but they also contact healthy cells along the way, which is why side effects can affect multiple body systems at once.
The Four Main Types
Chemotherapy
Chemotherapy uses drugs that kill rapidly dividing cells. Because cancer cells grow and divide faster than most normal cells, they’re especially vulnerable. These drugs work by interfering with DNA, RNA, or protein production inside cells, or by disrupting the machinery cells use to split in two. When enough of that interference accumulates, the cell dies.
The catch is that some healthy cells also divide quickly, particularly in bone marrow, the lining of the digestive tract, and hair follicles. That’s why chemotherapy commonly causes low blood counts, nausea, and hair loss. Most chemotherapy is given intravenously on a repeating schedule: treatment days followed by rest periods that give healthy tissue time to recover. Some chemotherapy drugs are taken as pills.
Targeted Therapy
Where chemotherapy attacks all fast-growing cells broadly, targeted therapy zeroes in on specific proteins or genetic features that drive a particular cancer. A well-known example is the drug trastuzumab, which locks onto a protein called HER2 found on certain breast cancer cells. Because the drug is designed to recognize that one protein, it can be highly effective against cancers that overexpress it while largely sparing cells that don’t.
Other targeted drugs block enzymes that cancer cells rely on to grow, or shut down the blood vessel signals that tumors use to feed themselves. Many of these are taken as daily pills rather than through an IV. The side effects tend to be different from chemotherapy’s, though they can still be significant depending on the drug and the pathway it interrupts.
Immunotherapy
Immunotherapy doesn’t attack cancer directly. Instead, it trains or unleashes your own immune system to do the job. Cancer cells often survive by putting the brakes on immune cells that would otherwise destroy them. The most widely used immunotherapy drugs, called checkpoint inhibitors, release those brakes. One class blocks a receptor called PD-1 on immune cells, preventing cancer from using it as a “don’t attack me” signal. Another blocks a molecule called CTLA-4 that normally dials down immune activation.
Because immunotherapy revs up the immune system broadly, it can cause a unique set of side effects driven by immune overactivity. Inflammation may show up in organs like the lungs, liver, thyroid, or intestines. Not every patient is a candidate for immunotherapy; it works best in cancers with certain biological characteristics, and it’s often combined with chemotherapy.
A newer form, CAR T-cell therapy, takes a patient’s own immune cells, genetically engineers them in a lab to recognize a specific cancer marker, then infuses them back into the body to hunt down tumor cells.
Hormone Therapy
Some cancers, particularly certain breast and prostate cancers, depend on hormones to grow. Hormone therapy either lowers the amount of a specific hormone in the body or blocks cancer cells from using it. For breast cancer that’s driven by estrogen, treatments may block estrogen receptors on tumor cells or shut down the enzyme that produces estrogen in the first place. For prostate cancer, the goal is typically to reduce testosterone levels or prevent testosterone from reaching cancer cells.
Hormone therapy is often taken as a daily pill and may continue for several years. Because it alters hormone levels body-wide, side effects can include hot flashes, joint stiffness, fatigue, and changes in bone density.
Antibody-Drug Conjugates: A Newer Approach
One of the more recent developments in systemic therapy is antibody-drug conjugates, or ADCs. These combine the precision of targeted therapy with the killing power of chemotherapy. An ADC is essentially a guided missile: a lab-made antibody that recognizes a specific protein on cancer cells is chemically linked to a potent toxic drug. The antibody delivers its payload directly to cells displaying the target protein, releasing the toxic agent once it’s inside.
Because the target protein is expressed at much higher levels on tumor cells than on normal cells, ADCs can concentrate their damage where it’s needed. Some newer ADCs also produce what’s called a “bystander killing effect,” releasing their toxic component into the space around the targeted cell so it damages neighboring tumor cells too, even if those neighbors express the target protein at lower levels. Third-generation ADCs have improved stability and wider safety margins compared to earlier versions.
How Systemic Therapy Fits Into a Treatment Plan
Systemic therapy can play different roles depending on when it’s used. When given before surgery, it’s called neoadjuvant therapy. The goal is to shrink a tumor so surgery is easier or more effective, and in some cases, to see how well the cancer responds to the drug. When given after surgery, it’s called adjuvant therapy, and the purpose is to destroy any cancer cells that may remain in the body but are too small to detect.
For cancers that have already spread to distant organs (metastatic disease), systemic therapy is often the primary treatment, since local approaches can’t reach every site. In many cases, doctors combine multiple types: chemotherapy with immunotherapy, or targeted therapy with hormone therapy, depending on the cancer’s specific biology.
How These Drugs Enter Your Body
The delivery method depends on the drug and the clinical situation. Intravenous infusion is the most common route for chemotherapy and immunotherapy because it puts the full dose directly into the bloodstream with rapid, predictable absorption. You’ll typically sit in a treatment chair for anywhere from 30 minutes to several hours per session.
Many targeted therapies and hormone therapies come as oral tablets or capsules, which you take at home on a daily schedule. Oral drugs pass through the liver before reaching general circulation, which can reduce the amount of active drug that makes it into the bloodstream. Doctors account for this when choosing doses. Subcutaneous injections, given just under the skin, offer a middle ground: they absorb more slowly than IV drugs but don’t require the same clinical setup. Some patients can give themselves subcutaneous injections at home.
Systemic Therapy Beyond Cancer
Though the term is most associated with oncology, systemic therapy applies to any condition treated with drugs that work throughout the body. Autoimmune diseases like psoriatic arthritis and rheumatoid arthritis are commonly managed with disease-modifying drugs that suppress or redirect immune activity body-wide. Severe psoriasis that doesn’t respond to creams or light therapy may require systemic medications, including some of the same biologic drugs used in cancer immunotherapy. The underlying principle is the same: the disease isn’t confined to one spot, so the treatment can’t be either.